CNBC Halftime Report Final Trades: AbbVie, Amazon, Datadog, Sixth Street Specialty Lending
TAO Synergies Inc TAOX
$4.51
▲ +4.40%
(+$0.19)
🎈 Low Float
Open
$4.40
Prev Close
$4.32
Day Range
$4.37 – $4.53
52W Range
$3.07 – $10.00
Market Cap
$32.33M
Beta
1.77
EPS (TTM)
$-3.38
📋 Company Profile
| Industry | Technology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-07 |
| Shares Out. | 7,470,000 |
| Website | synaptogen.com/ ↗ |
| Phone | 19732420005 |
| Employees | 4 |
| Revenue | $88,626 |
| Gross Profit | $88,626 |
| Net Income | -$9.3M |
| Free Cash Flow | -$6.2M |
| Total Assets | $21.1M |
| Total Liabilities | $3.8M |
| Equity | $12.7M |
About TAO Synergies Inc
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
TAO Synergies Inc is a publicly traded company under the ticker symbol TAOX on the NASDAQ NMS - GLOBAL MARKET, operating in the Technology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2025-04-01)